News archive

The UK News Archive contains resources intended for journalists only.

Showing 3 results

February 2025

Media Release Feb 04, 2025
Novartis Kisqali® (ribociclib) receives MHRA authorisation for the adjuvant treatment of HR+/HER2- early breast cancer at high risk of recurrence in a broad population of patients

The Medicines and Healthcare products Regulatory Agency (MHRA) have authorised a new indication for ribociclib as an adjuvant treatment option to be used in combination with an aromatase inhibitor (…

January 2025

Media Release Jan 13, 2025
Adults in Scotland with rare blood disorder to get access to new oral monotherapy on NHS

Scottish Medicines Consortium (SMC) has recommended Fabhalta®▼ (iptacopan) as monotherapy for adults with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia and used under the…

September 2024

Media Release Sep 04, 2024
Adults in England and Wales with rare blood disorder to get access to new oral monotherapy on NHS

The National Institute for Health and Care Excellence (NICE) has published final guidance (TA1000) recommending Fabhalta®▼(iptacopan) as a treatment option in eligible patients on the NHS in England…